Yogeeta B. Jadhav
Senior Technical Specialist – Chemistry
Yogeeta B. Jadhav
Senior Technical Specialist – Chemistry
Dr. Yogeeta Jadhav zet haar uitgebreide kennis van scheikunde en meer dan 15 jaar ervaring op het gebied van octrooien in om klanten te helpen bij het beschermen van hun uitvindingen. Haar brede ervaring omvat het opstellen en behandelen van octrooiaanvragen, het beoordelen van octrooieerbaarheid, het analyseren van vrijheid van handelen, niet-inbreuk en octrooigeldigheid, en due diligence-kwesties op een breed spectrum van technologieën, waaronder farmaceutica, nutraceutica, chemische samenstellingen en processen, kleine moleculen, vaccins, antilichaam-geneesmiddelconjugaten, geneesmiddelformuleringen, cannabis, voedingsmiddelen en dranken, persoonlijke verzorgingsproducten, batterijen, producten voor huisdieren, coatings en polymeren. Ze is lid van de afdeling Intellectueel Eigendom, de sector Gezondheidszorg & Levenswetenschappen en de praktijkgroep Chemie, Biotechnologie & Farmacie van het kantoor.
Prior to joining Foley, Yogeeta was a patent scientist at Sandoz India Pvt Ltd, the generic pharmaceuticals division of Novartis. She also worked as a research manager with Lupin Limited, a leading global pharmaceutical company based in Pune, India, where she assisted attorneys with respect to drafting, filing, and prosecuting patent applications; conducting infringement analysis; and evaluating new drug molecules for their patent situation, chemistry, process and technical complexity, and polymorph issues.
After completing her doctoral degree, Yogeeta was a postdoctoral fellow at Monash University in Australia, where she continued her doctoral research focused on the development of a catalytic process for the hydration of aromatic epoxides and phase transfer catalytic reactions in the organic process industry, including agrochemicals, pharmaceuticals, and perfumes, respectively. Her research has resulted in several journal publications and has been presented at national and international conferences.
Presentaties en publicaties
- “Role of the Omega Phase in the Analysis and Intensification of Solid-Liquid Phase-Transfer-Catalyzed Reactions,” Jadhav, Y.; Yadav, G., Langmuir, 18 (16), 5995–6002, 2002
- “Synthesis of 2, 4-dichlorophenoxyacetic acid: Novelties of Kinetics of Inverse Phase Transfer Catalysis,” Jadhav, Y.; Yadav, G., J. Mol Catalysis A: Chemical, 184 (1–2), 151–160, 2002
- “Kinetics and Modeling of Liquid-Liquid Phase Transfer Catalyzed Synthesis of p-chlorophenyl acetonitrile: Role of Co-catalyst in Intensification of Rates and Selectivity,” Jadhav, Y.; Yadav, G., J Molecular Catalysis A: Chemical, 192, 41–52, 2003
- “Cascade Engineered Phase Transfer Catalysis: A Novel Concept in Green Chemistry,” Jadhav, Y.; Yadav, G., Clean Tech. Environ. Policy, 6(1), 32–42, 2003
- “Novelties of Solid-Liquid Phase Transfer Catalyzed Synthesis of I-isopropyl-p-chlorophenyl acetonitrile from pchlorophenyl acetonitrile,” Jadhav, Y.; Yadav, G., Organic Process Research & Development, 7(4), 588-598, 2003
- “Novelties of Kinetics and Mechanism of Liquid-Liquid Phase Transfer Catalyzed Reduction of p-nitroanisole to p-anisidine,” Jadhav, Y.; Yadav, G.; Sengupta, S., Chem. Engg. Science, 55(12), 2681–2689, 2003
- “Selectively Engineered Phase Transfer Catalysis in the Synthesis of Fine Chemicals: Reactions of p-chloronitrobenzene with sodium sulphide,” Jadhav, Y.; Yadav, G.; Sengupta, J. Molecular Catalysis A: Chemical, 200, 117–129, 2003
Talen
- Hindi (vloeiend)
- Marathi (native)
Foley vertegenwoordigt Verona Pharma bij overname van $10B door Merck
USPTO Publishes Drug Patent and Exclusivity Study Report
Federaal Hof van Beroep onderzoekt octrooieerbaarheid van overlappende bereiken
USPTO bespreekt de plicht tot openbaarmaking en de plicht tot redelijk onderzoek
USPTO-FDA-luistersessie — Stemmen van patiënten en octrooibeschermers
